The European Commission’s decision is based on two Phase III trials where Tevimbra plus chemotherapy improved overall ...

The Food and Drug Administration (FDA) has approved Shorla Oncology‘s IMKELDI for the treatment of specific leukaemia cancer ...

See the new treatment that will break a Pfizer monopoly on a drug for heart disease.

Canada's health regulator has approved Novo Nordisk's weight loss drug Wegovy to reduce the risk of nonfatal heart attack or ...

The U.S. Food and Drug Administration has approved UCB's Bimzelx (bimekizumab-bkzx) for the treatment of adults with moderate ...

Bolivia’s highest court has approved the extradition to the United States of a former anti-narcotics chief on charges of ...

A new therapy for brittle type 1 diabetes, the only treatment currently approved by the U.S. Food and Drug Administration, is ...

The FDA has approved Attruby, a new oral treatment that helps reduce heart-related deaths and hospital visits among adults ...

Regulators need to know that our most important health care problem is not that people are taking too many prescription drugs ...

With approval, acoramaidis (Attruby; BridgeBio Pharma) becomes the first agent with a label specifying near-complete ...

The U.S. Food and Drug Administration has approved Kebilidi (eladocagene exuparvovec-tneq) for the treatment of adult ...

The FDA will review an application to consider potential approval of Nubeqa plus androgen deprivation therapy for metastatic ...